In this proof - of - principle study, the researchers showed, using DNA sequencing and karyotyping technologies, that the patient's
unique cell characteristics were maintained in both normal and tumor CR laboratory cells.
Not exact matches
To acquire and maintain its
characteristic features, each
cell type must express a
unique subset of genes.
On the fly, neurosurgeons can use the pen - sized instrument on the brain to view the tumor
cells with
unique fluorescent
characteristics that outline the tumor
cells.
To study the
characteristics of those
unique cells, Prof. Meshorer and doctoral student Alva Biran from the Hebrew University teamed up with Dr. Paula Scaffidi and Christina Morales Torres from The Crick Institute in London.
Vα14 invariant NKT (Vα14 iNKT)
cells are a population of T lymphocytes that have several
unique characteristics; many of these are related to their ability to function similarly to
cells of the innate as opposed to the adaptive immune system.
Our laboratory is interested broadly in the interface between the innate and adaptive immune systems, and the
unique subsets of T lymphocytes that bridge these systems by adopting properties that are very
characteristic of innate immune
cells.
A human embryonic stem
cell is reined in — prevented from giving up its
unique characteristics of self - renewal and pluripotency — by the presence of a protein modification that stifles any genes that would prematurely instruct the
cell to develop into heart or other specialized tissue.
We have recently identified which
cells are uniquely responsible for the metastasis formation in OSCC, and they exhibit the following
characteristics: i) they are exclusive in their ability to generate metastases; ii) they express the fatty acid translocase CD36, and express a
unique lipid metabolic signature; iii) they directly link metastasis predisposition to dietary fat content; iv) they increase their metastatic initiation potency when treated with palmitic acid; v) they are highly sensitive to CD36 inhibition, which almost completely abolishes their metastatic potential in preclinical models (Pascual et al., Nature 2016).
Determining how ES
cell genes are modified by these epigenetic markers may explain these
cells»
unique characteristics, said the scientists, who are based at the Genome Institute of Singapore (GIS) and the Bioprocessing Technology Institute (BTI), both under the Agency for Science, Technology and Research (A * STAR), as well as at the National University of Singapore (NUS).
Cedars - Sinai scientists can harvest
cells from the blood or skin of an individual and reprogram them into induced pluripotent stem
cells, which can be made into any organ
cell (such as those from the lung, liver or intestine), each bearing the
unique genetic fingerprint and
characteristics of the person.
These
cells can then be reprogrammed into induced pluripotent stem
cells, which can be made into any organ
cell, each bearing the
unique genetic fingerprint and
characteristics of the individual.
«This work highlights the power of combining advanced genome editing and synthetic DNA technologies to build novel
cells with
unique characteristics,» said Dr. Gibson, Vice President, DNA Technologies, SGI; Associate Professor, JCVI.
CRI postdoctoral fellow Dr. Haihui Lu at the Whitehead Institute for Biomedical Research in Cambridge, Massachusetts, is studying some of the
unique characteristics that differentiate metastatic cancer
cells from primary tumor
cells, and specifically aims to understand how these
unique characteristics enable breast cancer
cells to escape elimination by the immune system.
ES
cells provide new opportunities for developing and establishing new treatments, including transplantation tolerance induction, because of their
unique characteristics: lack of MHC antigens, poor expression of co-stimulatory molecules and lack of T
cells that can trigger graft - versus - host reaction.
Salt and cancer Balancing an iodine deficiency; 3 types of people In the 1st case of balancing an iodine deficiency Possible allergic reactions to taking iodine Lugol's iodine / iodide in Solution Dosage My use of the Iodoral 12.5 mg iodine / iodide tablet form Monitoring for activation of iodine Maintenance dose of iodine supplementation My iodine is not activating «person 2» Niacin and its
unique characteristics Niacin, bleeding and notes of caution My basal
cell temperature is normal / possible infection «person 3» Iodine Spot Loading Test Recapping the 3 types of people with iodine deficiency Tumors and topical application of iodine Cellect / Budwig protocol; step 4 addition of the nutritional product Cellect including Cellect / Budwig notations through observations